Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Fasting × CNS × Clear all

Phase

Status

Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4 Thoracic 3 Breast 3 Plasma cell 1 Other 1 Head & Neck 1 Genitourinary 1 Endocrine 1 CNS 1

Conditions

Brain Neoplasms 947 Glioblastoma 822 Glioma 541 Central Nervous System Neoplasms 396 Astrocytoma 355 Gliosarcoma 312 Neuroblastoma 294 Oligodendroglioma 229 Neoplasms 168 Medulloblastoma 147 Breast Neoplasms 134 Sarcoma 101 Ependymoma 100 Recurrence 94 Neoplasm Metastasis 86 Meningioma 84 Carcinoma, Non-Small-Cell Lung 79 Melanoma 78 Lymphoma 76 Neurofibromatosis 1 71 Precursor Cell Lymphoblastic Leukemia-Lymphoma 70 Wilms Tumor 69 Lung Neoplasms 68 Osteosarcoma 63 Lymphoma, Non-Hodgkin 61 Head and Neck Neoplasms 60 Ovarian Neoplasms 59 Burkitt Lymphoma 59 Testicular Neoplasms 57 Familial ependymoma 55

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01754350 2021-06-02

ERGO2

Johann Wolfgang Goethe University Hospital

Phase NA Completed

50 enrolled 5 charts

Fasting, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡